Hazel Hunt
Net worth: 18 M $ as of 2026-05-30
Net worth: 18 M $ as of 2026-05-30
Hazel Hunt currently works at Corcept Therapeutics, Inc., as Chief Scientific Officer from 2020.
Dr. Hunt also formerly worked at Pulmagen Therapeutics (Synergy) Ltd., as Operations Director from 2002 to 2011, Argenta Bank en Verzekeringsgroep NV, as Director-Chemistry & Operations from 2002 to 2011, the University of Oxford, as Principal, the University of California, Davis, as Principal, and Glaxo Group Research Ltd., as Senior Chemist.
Dr. Hunt received her undergraduate degree from The Australian National University and doctorate degree from The University of Southampton.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-26 | 255,437 ( 0.24% ) | 18 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Chief Tech/Sci/R&D Officer | 2010-12-31 |
| Companies | Position | End |
|---|---|---|
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for respiratory diseases | Chief Operating Officer | 2010-12-31 |
Argenta Bank en Verzekeringsgroep NV
Argenta Bank en Verzekeringsgroep NV Major BanksFinance Operates as a national commercial bank | Corporate Officer/Principal | 2010-12-31 |
Glaxo Group Research Ltd. | Corporate Officer/Principal | - |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Corcept Therapeutics, Inc.
Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian National University
Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for respiratory diseases | Commercial Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argenta Bank en Verzekeringsgroep NV
Argenta Bank en Verzekeringsgroep NV Major BanksFinance Operates as a national commercial bank | Finance |
Glaxo Group Research Ltd. |
Select your edition
All financial news and data tailored to specific country editions